Becton Dickinson (BDX) Reports In-Line Q4 EPS; Offers FY24 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/16/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- SanDisk upgraded at JPMorgan after investor day; shares climb
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Becton Dickinson (BDX) slumps after guidance disappoints investors
November 9, 2023 12:02 PM ESTShares of medical device maker Becton Dickinson (NYSE: BDX) declined Thursday after it reported quarterly results, along with guidance for 2024. Its outlook was viewed was well below Wall Street expectations and a disappointment to investors.
Becton Dickinson reported earnings per share for its fourth quarter that were in-line with consensus at $3.42. Revenue was slightly better than expected, coming in at $5.1 billion, compared to the consensus of $5.02... More
